Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Rossari Biotech LtdIndustry : Chemicals
BSE Code:543213NSE Symbol: ROSSARIP/E(TTM):32.19
ISIN Demat:INE02A801020Div & Yield %:0.07EPS(TTM):20.73
Book Value(Rs):194.562771Market Cap ( Cr.):3693.87Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 1202.91975.171072.84690.41600.09515.92
Excise Duty0.000.000.000.000.000.00
Net Sales1202.91975.171072.84690.41600.09515.92
Other Income 6.773.6012.709.723.631.27
Stock Adjustments 13.5812.9710.347.22-2.4415.96
Total Income1223.26991.741095.88707.35601.28533.15
EXPENDITURE :      
Raw Materials 910.72717.28833.02458.86369.26355.23
Power & Fuel Cost3.012.802.802.401.741.26
Employee Cost 51.4657.3543.5336.6637.1327.42
Other Manufacturing Expenses 44.2538.0437.5027.7526.6427.82
Selling and Administration Expenses 39.6442.2333.4937.9650.7138.06
Miscellaneous Expenses 6.147.8010.0512.677.164.45
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1055.23865.49960.39576.29492.65454.24
Operating Profit168.02126.25135.50131.06108.6478.91
Interest 9.704.622.552.993.683.27
Gross Profit158.32121.63132.95128.07104.9675.64
Depreciation24.1925.9826.2722.0716.8512.19
Profit Before Tax134.1395.65106.68106.0088.1163.45
Tax36.1625.9728.7227.5323.8017.84
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-1.67-1.71-1.51-0.63-1.22-0.18
Reported Net Profit99.6571.3979.4779.1065.5245.79
Extraordinary Items 2.200.421.420.32-0.050.00
Adjusted Net Profit97.4570.9778.0578.7865.5745.79
Adjst. below Net Profit -0.010.340.010.13-5.51-0.23
P & L Balance brought forward380.11311.13234.40157.71100.3465.27
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 2.762.752.752.542.6510.49
P & L Balance carried down476.98380.11311.13234.40157.71100.34
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %25.0025.0025.0025.0025.000.00
Earnings Per Share-Unit Curr18.0412.9414.4415.2312.9120.81
Earnings Per Share(Adj)-Unit Curr18.0412.9414.4415.23NANA
Book Value-Unit Curr173.83155.69142.5077.8855.8554.70